Herregods G, Van Camp J, Morel N, Ghesquire B, Gevaert K, Vercruysse L, et al
If cagrilintides clinical benefit rests primarily on sustained central satiety rather than on persistent gastric slowing, then the titles framing cagrilintide as a gastric-emptying and postprandial-metabolism agent describes the compounds acute pharmacology more accurately than its chronic steady-state behavior
Editorial disclaimer: this comparison is educational, not a purchase recommendation
Beard JR, Officer A, Carvalho IA, Sadana R, Pot AM, Michel JP, Lloyd-Sherlock P, Epping-Jordan JE, Peeters GM, Mahanani WR, Thiyagarajan JA, Chatterij S (2016) The world report on ageing and health: a policy framework for healthy ageing
Some scholars have noted how the drugs consistently reduced eating behavior triggered by appetizing smells, the visual appeal of food, or observing others eat. Why the GLP-1 Dopamine Shift Can Be Dangerous At a glance, uncoupling your reward circuitry from food seems like a no-brainer when youre trying to lose weight